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The hypothalamic–pituitary–adrenal (HPA) axis is activated by stress. This involves the production of
corticotropin releasing hormone (CRH) with the subsequent release of proopiomelanocortin (POMC) peptides,
of which adrenocorticotropin hormone (ACTH) is most important. Although the skin has the capacity to
produce CRH and POMC peptides, the immunomodulatory roles of ACTH in skin are yet unknown. IL-18 has
been known to affect cells involved in the inflammatory response. In this study, we aimed to identify the
regulatory effect of ACTH on IL-18 expression of skin keratinocytes. Exposure of HaCaT cells to ACTH stimulated
formation of IL-18 mRNA transcript and its protein products in a dose-dependent manner. Furthermore, we
suggest that ACTH-induced IL-18 production is via the caspase-1 activation pathway, as IL-18 production induced
by ACTH could be suppressed by caspase-1 inhibitor, and ACTH could increase caspase-1 activity. The effect of
ACTH on IL-18 production was blocked by specific inhibitors of p38 kinase (SB203580) or extracellular signal-
regulated kinase (ERK) (PD98059). In addition, ACTH-induced rapid phosphorylation of p38 kinase and ERK, and
ACTH signaling occurred via melanocortin receptor 1 (MC1R) and receptor 2 (MC2R). These results suggest that
ACTH stimulates IL-18 expression in human keratinocytes, which provides an insight into the interaction
between ACTH and inflammatory mediators.
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INTRODUCTION
As an adaptive response to systemic stress, the hypothalamic–
pituitary–adrenal (HPA) axis is activated (Chrousos, 1995).
The process starts with the hypothalamic release of cortico-
tropin-releasing hormone (CRH) which, in turn stimulates
production of adrenocorticotropic hormone (ACTH) and
other proopiomelanocortin (POMC) peptides via CRH
receptor type 1 (CRH-R1). ACTH, a 39-amino-acid peptide,
regulates glucocorticoid production through its effect on the
adrenal cortex. Steroids are powerful anti-inflammatory
agents that counteract stressors and buffer tissue damage
(Chrousos, 1995). Recent evidence suggests that ACTH is
produced outside the pituitary tissue, which includes the skin
(Chakraborty et al., 1996; Wakamatsu et al., 1997; Slominski
et al., 2000a). Slominski et al. have acknowledged the skin as a
cutaneous equivalent of the central HPA (Slominski and Mihm,
1996; Slominski et al., 2000b, 2001, 2004a). Although similar
to its systemic equivalent, the cutaneous HPA axis is responsive
to local stressors (solar, thermal, chemical, biological, etc.) and
resultantly activates the neuronal, endocrine, and immune
systems in the skin. A variety of cytokines (e.g., IL-1b, IL-6, and
TNF-a) are upregulated by stress, suggesting their role in
mediating stress responses (Dugue et al., 1993). However, the
molecular mechanism of stress-induced cytokine in impairing
host defenses is not well understood.
IL-18 was originally discovered as IFN-g-inducing factor
(Okamura et al., 1995; Ushio et al., 1996). It is normally
expressed in its precursor form (24 kDa), but can be activated
(18 kDa) by caspase-1 (IL-1b-converting enzyme) (Ghayur
et al., 1997; Gu et al., 1997). IL-18 performs multiple
biological activities, which include Fas (CD95, APO-1)
ligand induction, enhancement of T-cell cytolytic activity,
and production of T helper type 2 (Th2) cytokines (Hoshino
et al., 1999; Yoshimoto et al., 2000; Nakanishi et al., 2001).
IL-18 is expressed in a wide range of cells, including Kupffer
cells, activated macrophages, keratinocytes, intestinal epithe-
lial cells, osteoblasts, and adrenal cortex cells. It plays an
important role in the Th1 response to toxic shock and shares
functional similarities with IL-12 (Dinarello, 1999). As a
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proinflammatory cytokine, overproduction of IL-18 induces
severe inflammatory disorders. Thus, it is important to know
how IL-18 expression is regulated in inflammatory response
and in maintaining the balance of immune system function.
Recently, IL-18 by keratinocytes was reported to play an
important role in response to cutaneous inflammation (Mee
et al., 2000).
In this study, we investigated the effect of ACTH on IL-18
expression of human HaCaT keratinocytes, and also exam-
ined its regulatory mechanism.
RESULTS
Effect of ACTH on IL-18 production in HaCaT cells
To measure the effect of ACTH on IL-18 expression in HaCaT
cells, we treated the cells with the fixed concentrations of
ACTH, and then assessed IL-18 mRNA and its protein
expression by reverse transcriptase-PCR and ELISA, respec-
tively. IL-18 mRNA expression was increased in a dose-
dependent manner by ACTH, with the peak response at
109 M (Figure 1a). IL-18 assessed by ELISA was also
increased in a dose-dependent manner (Figure 1b). As shown
in Figure 1, IL-18 mRNA expression and its production were
significantly stimulated by ACTH in a dose-dependent
manner.
Induction of caspase-1 by ACTH
Because caspase-1 is required for cleaving pro-IL-18 into its
mature form, its involvement in IL-18 production was
examined by pretreating HaCaT cells for 2 hours with the
caspase-1-specific inhibitor Ac-YVAD-CHO before stimula-
tion with ACTH. We observed Ac-YVAD-CHO to suppress
the production of IL-18 (Figure 2a). Next, we investigated the
molecular mechanism underlying ACTH-induced IL-18
production by performing caspase-1 colorimetric assay.
Caspase-1 activity in HaCaT cells were elevated 10-fold by
ACTH (Figure 2b). The results indicate that ACTH is involved
in IL-18 production of HaCaT cells probably via a caspase-1
activation pathway. In a previous report, caspase-1 was
activated by caspase-11 (Wang et al., 1998). It has also been
reported that caspase-11 can be activated by cathepsins B
(Schotte et al., 2001). To understand the involvement of
caspase-11 in the ACTH-induced caspase-1 activation, we
examined it by using Z-FA-FMK, an inhibitor of cathepsins B.
In our observation, Z-FA-FMK suppressed the production of
IL-18 induced by ACTH, indicating that caspase-11 is also
involved in the ACTH-induced IL-18 production in HaCaT
cells (Figure 2c).
Effect of mitogen-activated protein kinase inhibitors on IL-18
expression
The mitogen-activated protein kinases (MAPKs) control a
wide variety of cellular events, which include very complex
cellular programs such as cell differentiation, proliferation
and apoptosis to processes involved in immune responses. To
identify its involvement in ACTH-induced IL-18 expression,
HaCaT cells were treated with 10 mM of p38 MAPK inhibitor
(SB203580) or extracellular signal-regulated kinase (ERK)
inhibitor (PD98059) for 2 hours before adding ACTH (1 nM).
We then assessed the expression of IL-18 mRNA transcripts
and its products. As shown in Figure 3, both SB203580 and
PD98059 had an inhibitory effect over ACTH on IL-18 mRNA
expression and its production.
To further identify the role of MAP kinase signaling
pathways in ACTH-induced IL-18 expression, HaCaT cells
were treated with ACTH, and the phosphorylation status of
p38 kinase and ERK were analyzed by immunoprecipitation
and Western blotting using commercially available anti-
bodies specific for the active forms of the two kinases. ACTH
induced transient phosphorylation of both p38 MAP kinase
and ERK. The maximal activation of p38 kinase and ERK by
ACTH was observed after 5 minutes (Figure 4a and b). These
data demonstrate that ACTH stimulates IL-18 production
through p38 kinase and ERK signaling pathways.
Melanocortin receptor 1 and MC2R expression in HaCaT cells
To study whether melanocortin receptor 1 (MC1R) and/or
MC2R are involved in the mediating ACTH-induced IL-18
production in HaCaT cells, the cells were treated with ACTH
and then MC1R and MC2R were analyzed by Western blotting.
ACTH (nM) Control 10−11 10−10 10− 9 10− 8



















































Figure 1. Effects of ACTH on the mRNA expression and production of IL-18
in HaCaT keratinocytes. (a) HaCaT cells were harvested after ACTH treatment
for 6 hours. Total RNA was extracted, and cDNA was synthesized for reverse
transcriptase-PCR. The histogram shows the IL-18 mRNA expression level
relative to b-actin by densitometry. (b) Cells were treated with indicated
concentration of ACTH for 24 hours. Cell supernatants were collected and
then IL-18 concentration was measured by ELISA, each performed in
triplicate. Data are mean7SD. *Po0.05 versus control.
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We determined that MC1R and MC2R were both expressed on
HaCaT cells (Figure 5a). Next, we used anti-MC1R and anti-
MC2R antibody to examine whether they could neutralize the
ACTH-induced IL-18 production. Anti-MC2R antibody was
more effective and almost reduced it to the control level
(Figure 5b). These results suggest that the induction of IL-18 by
ACTH may be mainly mediated by MC2R.
Effect of ACTH on IL-18 production in human primary
keratinocytes
To see whether ACTH regulates IL-18 production in primary
human epidermal keratinocytes, we assessed IL-18 produc-
tion by ELISA. As shown in Figure 6a, IL-18 production was
significantly stimulated by ACTH treatment in human primary
keratinocytes. Next, we observed that caspase-1 activity in
primary human epidermal keratinocytes was stimulated by
ACTH (Figure 6b). Ac-YVAD-CHO, a caspase-1 inhibitor,
effectively suppresses IL-18 production by ACTH in primary
human epidermal keratinocytes, as shown in the result from
human keratinocyte cell line HaCaT (Figure 6a). In the end,
we showed that SB203580 and PD98059 could suppress the
ACTH-induced IL-18 production, suggesting that p38 kinase
and ERK were both involved in the signaling pathway in
primary human epidermal keratinocytes (Figure 6c).
DISCUSSION
In this study, we investigated the regulatory effect of ACTH -
on expression of IL-18 in HaCaT and normal keratinocytes.
Our results show that ACTH stimulates human keratinocytes
to secrete IL-18 through MC1R and MC2R. Furthermore,
ACTH activates the MAPK p38 and ERK pathways that are
further required for IL-18 expression.
In response to systemic stress, CRH stimulates the pituitary
CRH-R, which leads to production and secretion of POMC-
derived peptides, including melanocyte-stimulating hormone
(MSH) and ACTH (Chrousos, 1995). Recent evidence
suggests that CRH stimulation of corticosteroids production
in melanocytes and dermal fibroblasts is mediated by ACTH
(Slominski et al., 2005a, b). CRH, CRH-R, and POMC genes
are expressed in human skin as well as in cultured
keratinocytes and melanocytes (Slominski et al., 1993,
1995, 2001, 2004a, b). Slominski et al. (2000b, 2001)
proposed that an equivalent of HPA axis, composed of the
CRH-CRHR-POMC loop, is conserved in the skin that may be
activated in a skin stress response system. Recently, MSH and
ACTH act as regulators of skin pigmentation and inhibitors of
the skin immune systems (Luger et al., 1998; Slominski et al.,
2004a, b). In this study, ACTH induced IL-18 production,
which is known as an inflammatory cytokine. However, it is
also known that the closely related POMC peptide alpha-
MSH exhibits anti-inflammatory effects through MC1R in
keratinocytes (Pavey and Gabrielli, 2002). To date, five
melanocortin receptors are known, and they have a variety of
important biological functions (Bohm et al., 2006). To
understand the difference between ACTH and alpha-MSH,

























































Figure 2. Caspase-1 is essential for the ACTH-induced IL-18 production in HaCaT keratinocytes. (a) HaCaT cells were pretreated with 40mM of the caspase-1
inhibitor Ac-YVAD-CHO for 1 hour, and then challenged with 1 nM ACTH. The IL-18 concentration in the culture supernatants was measured by ELISA,
each performed in triplicate. (b) Cells were stimulated with 1 nM ACTH for 6 hours. Caspase-1 enzymatic activity was assayed with a caspase-1 colorimetric
assay kit according to the manufacturer’s instruction. The data normalized to the negative control are shown as fold increases in caspase activity. (c) Effects
of Z-FA-fmk on ATCH-induced IL-18 production. HaCaT cells were pretreated with 20 mM of Z-FA-FMK for 2 hours, and then stimulated with 1 nM ACTH.
The IL-18 concentration in the supernatant was measured by ELISA, each performed in triplicate. Data are mean7SD. *Po0.05 versus control, yPo0.05
versus ACTH treated group.
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Figure 5 showed that ACTH signals through MC1R and
MC2R. This might be an explanation for the differential
effects of ACTH and alpha-MSH in inflammation as MC1R
and MC2R have different signal pathways (Bohm et al.,
2006). IL-18 has multiple and complicated functions as it
participates in innate immunity and in Th1- and Th2-
mediated responses. During inflammation, the activation of
the stress system, through induction of a Th2 shift, protects
the organism from systemic ‘‘overshooting’’ with Th1/pro-
inflammatory cytokines. Interestingly, it has been reported
that the expression of IL-18 is markedly increased in
suprabasal keratinocytes in psoriatic lesions (Naik et al.,
1999; Ohta et al., 2001), raising the possibility that IL-18
expression is upregulated in differentiated keratinocytes.
Therefore, ACTH induced IL-18 expression by keratinocytes
may provide new insights into the mechanism underlying the
pathogenesis of skin disorders.
In a previous report, cytokines IL-1b and IL-6 were able to
stimulate CRH secretion from the hypothalamus (Navarra
et al., 1991), and IL-18 was originally identified as a member
of the IL-1 family (Dinarello, 1999) and expected to be able to
stimulate CRH production. Interestingly, recent evidence
documented that IL-18 inhibited basal and stimulated CRH
secretion from isolated rat hypothalami, and reduced CRH
gene expression (Tringali et al., 2005). We have recently
reported that CRH inhibits IL-18 expression in HaCaT cells,
suggesting that IL-18 and CRH act antagonistically to each
other (Park et al., 2005). Conti et al. (2000) have shown that
the production of IL-18 in the adrenal cortex is stimulated by
ACTH and cannot be inhibited by the direct action of
corticosterone. In this study, we also showed that IL-18 mRNA
expression and its production were significantly stimulated by
ACTH in a dose-dependent manner in HaCaT keratinocytes





























































Figure 3. Effects of the p38 MAPK inhibitor SB203580, or the ERK inhibitor
PD98059 on ACTH-induced IL-18 expression in HaCaT cells. HaCaT cells
were pretreated with SB203580 (10 mM) or PD98059 (10 mM) for 2 hours
before addition of 1 nM of ACTH. (a) Total RNA was extracted at 6 hours
following ACTH treatment, and cDNA was synthesized for reverse
transcriptase-PCR. The histogram shows the IL-18 mRNA expression level
relative to b-actin by densitometry. (b) After cells were harvested for 24 hours,
IL-18 concentration was measured by ELISA, each performed in triplicate.
























































Figure 4. Effects of ACTH on activation of MAPKs in HaCaT cells. HaCaT
cells were treated with 1 nM of ACTH for indicated time periods.
Phosphorylation of (a) p38 kinase and (b) ERK were analyzed by
immunoprecipitation and Western blot as described in Materials and
methods. After cells were harvested for 5 minutes, phosphorylation of p38
kinase and ERK were analyzed by immunoprecipitation and Western blot.
The band intensities were quantitated. Data are mean7SD. *Po0.05 versus





























Figure 5. Involvement of MC1R and MC2R in ACTH-induced IL-18
production. (a) HaCaT cells were treated with 1 nM of ACTH. After that, cells
were harvested for 24 hours. The expression level of MC1R and MC2R were
analyzed by Western blot. (b) Cells were pretreated with anti-MC1R (2 mg/mL)
or anti-MC2R antibody (2 mg/mL) for 1 hour and then incubated with 1 nM of
ACTH for 24 hours. The supernatants were collected and then IL-18
concentration was measured by ELISA, each performed in triplicate. Data are
mean7SD. *Po0.05 versus control, yPo0.05 versus ACTH treated group.
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important role on the negative feedback loop, CRH upregulat-
ing POMC and, subsequently, ACTH leads to the induction of
IL-18, and then the downregulation of CRH.
Sugama et al. (2000) have reported differential IL-18
promoter usage in the adrenal gland and immune cells with
adrenal gland-specific expression of IL-18 mRNA by ACTH,
suggesting that IL-18 may be induced in the adrenal gland
during stress. Besides, Sekiyama et al. (2005) demonstrated
that ACTH can enhance IL-18 production through super-
oxide-mediated caspase-1 activation and p38 MAPK kinase.
In these studies, animal models were used to show the
systematic effects of ACTH by injecting ACTH into the
animals. In this study, the aim was to test the direct effect of
ACTH in keratinocytes and to compare the difference
between the adrenal glands and keratinocytes. The results
showed for the first time that ACTH can directly regulate
immune functions of keratinocytes, and that the mechanism
was the same as that of the adrenal gland. These findings
suggest that caspase-1 activation and p38 MAPK kinase
pathways are commonly involved in ACTH-induced IL-18
production.
In conclusion, we demonstrated that ACTH stimulates IL-
18 expression by phosphorylation of p38 and ERK MAPK
signaling pathway. Therefore, our findings may provide an
insight into cellular interactions between ACTH and inflam-
matory mediators. Because IL-18 is involved in both Th1 and
Th2 functions, the ability of ACTH to induce the production
of inflammatory mediators by keratinocytes provides a new
mechanism for the involvement of ACTH in innate and




The human keratinocyte cell line HaCaT was cultured in RPMI
1640 (Gibco-BRL, Gaithersburg, MD) medium supplemented with
2mM L-glutamine, antibiotics (100 U/ml penicillin G and 100 mg/ml
streptomycin) and 10% heat-inactivated fetal bovine serum (FBS)
(Gibco-BRL). This cell line was used for experiments while in their
log phase of growth. Primary cultures of normal human epidermal
keratinocytes were prepared from foreskin of three children who
underwent circumcision. The ethical committee of the Catholic
University of Korea approved the study, and all patients provided
an informed consent. Our experiments adhered to the Declaration
of Helsinki Principles. Skin specimens were cut into small pieces
and incubated overnight in dispase II (2.4 U/ml; Roche Applied
Science, Mannheim, Germany) at 41C. The epidermis was
detached from the dermis with fine forceps and incubated in
Hank’s solution with 0.25% trypsin (Gibco-BRL) for 20 minutes at
371C. Trypsin activity was stopped by adding FBS. The cell
suspension passed through a 40 mm sterile gauze and the
keratinocytes obtained were washed twice. Freshly isolated
keratinocytes were cultured in keratinocyte basal medium (Bio-
Whittaker, Heidelberg, Germany) with full supplements (0.1 ng/ml
human epidermal growth factor, 0.5 mg/ml hydrocortisone, 5 mg/ml
insulin, 7.5 mg/ml bovine pituitary extract, 50 mg/ml gentamicin,
50 ng/ml amphotericin-B, and 0.15 mM calcium) according to the







































































Figure 6. Effects of ACTH on the production of IL-18 in primary human epidermal keratinocytes. (a) Primary human epidermal keratinocytes were
pretreated with or without Ac-YVAD-CHO (40mM) for 2 hours before addition of 1 nM of ACTH for 24 hours. Cell supernatants were collected and then
IL-18 concentration was measured by ELISA, each performed in triplicate. (b) Cells were stimulated with 1 nM ACTH for 6 hours. Caspase-1 enzymatic
activity was assayed with a caspase-1 colorimetric assay kit according to the manufacturer’s instruction. The data, normalized to the negative control, are
shown as fold increases in caspase activity. (c) Cells were treated with or without SB203580 (10 mM) or PD98059 (10mM) for 2 hours before addition of 1 nM
of ACTH for 24 hours. Supernatants were collected and then IL-18 concentration was measured by ELISA, each performed in triplicate. Data are mean7SD.
*Po0.05 versus control, yPo0.05 versus ACTH treated group.
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atmosphere containing 5% CO2 at 371C and were used at the
passage two to five.
Cell treatment with inhibitors
HaCaT cells were seeded at a density of 1 106 cells/100-mm
dishes. After 48 hours, the cells were washed with a serum-free
medium and then placed at least 16 hours before experiments in a
media without FBS. The cells were pretreated with 10 mM SB203580
(Sigma, St Louis, MO), a p38 MAPK inhibitor, 10 mM PD98059
(Sigma), an ERK inhibitor, 40 mM Ac-YVAD-CHO (SantaCruz
Biotechnology, Santa Cruz, CA), an IL-1b-converting enzyme/
caspase-1 inhibitor, or 20 mM Z-FA-FMK (R&D systems, Minneapolis,
MN), a cathepsin-B inhibitor for 2 hours in a serum-free medium. We
added human ACTH (1011 MB108 M) to the cells, which was
purchased from Sigma.
Treatment of cells with Anti-MC1R and Anti-MC2R antibody
HaCaT cells were pretreated with anti-MC1R or anti-MC2R
antibodies (SantaCruz Biotechnology) for 1 hour in serum-free
medium. The cells were washed with serum-free medium and then
ACTH (1 nM) was added to the cells and incubated for 24 hours.
Reverse transcription-PCR
After treatment, total RNA was extracted from HaCaT cells using the
EasyBlue reagent (iNtRON, Inc., Sungnam, Korea). The reverse
transcription was performed using a power cDNA synthesis kit
(iNtRON, Inc.). IL-18 primers were: forward, 50-AGGAATAAA
GATGGCTGCTGAAC-30; reverse, 50-GCTCACCACAACCTCTACC
TCC-30. The PCR amplification process consisted of 32 cycles of
951C for 1 minute; 601C for 1 minute; and 721C for 45 seconds.
Human b-actin primers were: forward, 50-GGCCATCTCTTGCTC
GAAGT-30; reverse, 50-GCCCAGAGCAAG AGAGGCAT-30. The
PCR amplification process consisted of 30 cycles of 941C for
30 seconds; 561C for 30 seconds; and 721C for 1 minute. Reaction
products subjected to electrophoresis on 2.0% agarose gel were
visualized with ethidium bromide. Signal strengths were quantified
using a densitometric program (Quantity One 1-D Analysis software,
Bio-Rad Laboratories, Hercules, CA). After normalizing versus b-
actin intensity, the increase or decrease in percentage was
determined for each gene. Each experiment was repeated at least
three times.
IL-18 ELISA
The concentration of IL-18 in the culture supernatant was measured
by a commercially available ELISA (MBL Medical & Biological
Laboratories Co., Ltd, Nagoya, Japan). After stimulation, cell culture
supernatants were collected, concentrated ( 30) by a microcon
(Millipore, Bedford, MA), and then added to coated wells. After
adding diluted biotinylated anti-IL-18 antibody to the wells, they
were incubated for 3 hours at room temperature. After washing for
four times with phosphate-buffered saline-Tween-20 (pH 7.4),
streptavidin-horseradish peroxidase conjugated anti-human IL-18
antibody was added, which was incubated for an hour. The wells
were washed four times with PBS-Tween-20, and substrate solution
was added, which was incubated for an hour. Relative absorbance
was measured at 450 nm, and the IL-18 concentration was
calculated using a standard curve. Each supernatant was analyzed
in triplicate.
Measurement of caspase-1 activity
The caspase-1 activity assay was performed with an enzyme activity
assay kit (Caspase-1 Colorimetric Assay kit, R&D systems) according
to the manufacturer’s instructions. After stimulation, the cell pellets
were lysed in a cell lysis buffer. The protein concentration was
determined using a BCA kit (Pierce, Rockford, IL). To 50 ml of cell
lysate (200 mg protein), 50 ml of 2 reaction buffer (containing DTT
10 mmol/l) and 5ml of the 4mmol/l caspase-1 colorimetric substrate
(WEHD-pNA) were added, and the mixture was incubated at 371C
for 2 hours. The samples were read at 405 nm with a spectro-
photometer.
Immunoprecipitation and Western blot analysis
Whole-cell lysates were prepared by extracting proteins using a
buffer containing 50 mM Tris-HCl (pH 7.5), 1 mM EDTA, 1 mM EGTA,
150 mM NaCl, 1% Nonidet P-40, 0.1% SDS, 1 mM Na3VO4, 1mg/ml
leupeptin, and 1 mM freshly added phenylmethylsulfonyl fluoride. To
detect the phosphorylated form of p38 MAPK, the lysates were then
immunoprecipitated with 2mg of anti-phosphotyrosine antibody and
25 ml of protein-A agarose for 3 hours at 41C. After washing three
times (20 minutes at 41C) with lysis buffer, the proteins bound to the
beads were solubilized in elution buffer consisting of 1 M Tris (pH
6.8) and 0.1% SDS. The protein concentration was measured using
the Bio-Rad Protein Assay Kit (Bio-Rad Laboratories). Equal amounts
of protein were resolved by 10% SDS-PAGE, blotted onto
nitrocellulose membranes and immunostained with anti-p38 MAPK
antibody. Blots were processed using horseradish peroxidase-
conjugated secondary antibodies and enhanced chemiluminescence
(ECL Detection Kit, Amersham Biosciences, Piscataway, NJ). To
detect MC1R, MC2R, and the phosphorylation level of ERK and p38
MAPK, ACTH-treated and untreated cells were lysed with lysis buffer
containing 1% Nonidet P-40, 0.5% sodium deoxycholate, 1.0%
SDS, 1 mM EDTA, 1 mM EGTA, 1 mM sodium orthovanadate, 1 mM
leupeptin, and 1 mM phenylmethylsulfonyl fluoride in PBS (pH 7.4).
Whole-cell lysates were directly resolved by 10% SDS-PAGE and
transferred to nitrocellulose membranes. Membranes were blocked
for 1 hour in PBS containing 0.1% (v/v) Tween-20 and 5% (w/v) non-
fat milk proteins. Blocked membranes were then incubated with
primary antibodies (MC1R, MC2R rabbit polyclonal IgG antibodies
at the final concentration of 1:50, Santa Cruz Biotechnology;
phospho-ERK, total ERK or p38 rabbit polyclonal antibodies at the
final concentration of 1:1,000, Cell Signaling, Beverly, MA) over-
night at 41C, washed three times (5 minutes each) with PBS
containing 0.1% Tween-20, and incubated with a horseradish
peroxidase-conjugated secondary antibody (1:2,000) for 1 hour at
room temperature. The bands were visualized by an enhanced
chemiluminescence detection system (Amersham Biosciences). The
band intensities were quantified using the Bio-Rad imaging system,
and the quantity of the phosphorylated proteins was expressed as
ratio of the phosphorylated over total protein in each case.
Statistical analysis
The statistical significance was performed using Student’s t-test.
Mean differences were considered to be significant when Po0.05.
The results are shown as the mean7SD.
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